CO5670360A2 - EXPANDABLE GASTRIC RETENTION DEVICE - Google Patents

EXPANDABLE GASTRIC RETENTION DEVICE

Info

Publication number
CO5670360A2
CO5670360A2 CO04023075A CO04023075A CO5670360A2 CO 5670360 A2 CO5670360 A2 CO 5670360A2 CO 04023075 A CO04023075 A CO 04023075A CO 04023075 A CO04023075 A CO 04023075A CO 5670360 A2 CO5670360 A2 CO 5670360A2
Authority
CO
Colombia
Prior art keywords
retention device
gastric retention
expandable gastric
expandable
polysaccharide
Prior art date
Application number
CO04023075A
Other languages
Spanish (es)
Inventor
James W Ayres
Original Assignee
Oregon State Board Of Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon State Board Of Higher Education filed Critical Oregon State Board Of Higher Education
Publication of CO5670360A2 publication Critical patent/CO5670360A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

1.- Un dispositivo de retención gástrico que comprende un gel formado de un polisacárido, el dispositivo está formado de un tamaño adecuado para administración a un sujeto.1.- A gastric retention device comprising a gel formed of a polysaccharide, the device is formed of a size suitable for administration to a subject.

CO04023075A 2001-08-16 2004-03-12 EXPANDABLE GASTRIC RETENTION DEVICE CO5670360A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31307801P 2001-08-16 2001-08-16

Publications (1)

Publication Number Publication Date
CO5670360A2 true CO5670360A2 (en) 2006-08-31

Family

ID=23214285

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04023075A CO5670360A2 (en) 2001-08-16 2004-03-12 EXPANDABLE GASTRIC RETENTION DEVICE

Country Status (14)

Country Link
EP (1) EP1416914A1 (en)
JP (1) JP2005501097A (en)
KR (1) KR20040032918A (en)
CN (1) CN1543337A (en)
BR (1) BR0117123A (en)
CA (1) CA2456976A1 (en)
CO (1) CO5670360A2 (en)
IL (1) IL160363A0 (en)
MX (1) MXPA04001388A (en)
NO (1) NO20040611L (en)
NZ (1) NZ531461A (en)
PL (1) PL368327A1 (en)
WO (1) WO2003015745A1 (en)
ZA (1) ZA200402066B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2466808C (en) * 2001-11-21 2009-01-27 E-Z-Em, Inc. Formulations for use in medical or diagnostic procedures
US20050142187A1 (en) * 2003-12-24 2005-06-30 Treacy Donald J.Jr. Enhanced absorption of modified release dosage forms
US7785291B2 (en) 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US7699863B2 (en) 2005-03-01 2010-04-20 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
WO2008011496A2 (en) * 2006-07-19 2008-01-24 Smithkline Beecham Corporation Method for radiolabeling formulations for gamma scintigraphy assesment
CN102552103B (en) * 2010-12-20 2013-11-20 西安力邦医药科技有限责任公司 Lamivudine solid dispersion, and preparation method, pharmaceutical composition and use of the dispersion
DK2858604T3 (en) 2012-06-07 2024-05-21 Epitomee Medical Ltd EXPANDED DEVICE
US11129793B2 (en) 2013-12-05 2021-09-28 Epitomee Medical Ltd Retentive devices and systems for in-situ release of pharmaceutical active agents
US10849853B2 (en) 2014-06-11 2020-12-01 Massachusetts Institute Of Technology Self-assembled residence devices and related methods
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
WO2016178971A1 (en) 2015-05-01 2016-11-10 Massachusetts Institute Of Technology Triggerable shape memory induction devices
EP3364946A4 (en) 2015-10-23 2019-06-26 Lyndra, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
ES2963058T3 (en) 2015-12-08 2024-03-25 Lyndra Therapeutics Inc Geometric configurations for gastric residence systems
US11576866B2 (en) 2016-09-30 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
EP3740189A1 (en) * 2017-12-18 2020-11-25 Tris Pharma, Inc. Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release
TR201914116A2 (en) * 2019-09-17 2021-04-21 Univ Yeditepe PRODUCTION METHOD OF NATURAL BIOMATERIALS AND CRYOGELS AND THE USE OF THESE CRYOGELS AS SOFT TISSUE SCACHE OR DRUG CARRIER SYSTEM
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
DE4406424A1 (en) * 1994-02-28 1995-08-31 Bayer Ag Expandable dosage forms
ES2234139T3 (en) * 1997-08-11 2005-06-16 Alza Corporation DOSAGE FORM OF AN ACTIVE PROLONGED RELEASE AGENT ADAPTED FOR GASTRIC RETENTION.
UA73287C2 (en) * 1998-09-14 2005-07-15 Ranbaxy Lab Ltd Ciprofloxacin formulation with delayed release
JP2000256216A (en) * 1999-03-04 2000-09-19 Meiji Milk Prod Co Ltd Gel composition
HUP0301465A3 (en) * 2000-06-23 2006-07-28 Teva Pharma Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition

Also Published As

Publication number Publication date
CA2456976A1 (en) 2003-02-27
EP1416914A1 (en) 2004-05-12
JP2005501097A (en) 2005-01-13
IL160363A0 (en) 2004-07-25
PL368327A1 (en) 2005-03-21
BR0117123A (en) 2004-09-28
KR20040032918A (en) 2004-04-17
NO20040611L (en) 2004-04-16
MXPA04001388A (en) 2004-05-27
CN1543337A (en) 2004-11-03
WO2003015745A1 (en) 2003-02-27
ZA200402066B (en) 2005-05-09
NZ531461A (en) 2008-03-28

Similar Documents

Publication Publication Date Title
CO5670360A2 (en) EXPANDABLE GASTRIC RETENTION DEVICE
DE69907977D1 (en) Pyrrolobenzodiazepine
CY1109955T1 (en) BUPROPION HYDROCHLORINE MODIFIED LABEL
BRPI0109198B8 (en) plaster having a support
SV2002000520A (en) DERIVATIVES OF PIRAZOL REF. PCS10927AAJR / BB
ES2189768T3 (en) REGIONAL ELEMENTARY SYNTHESIS OF RAPAMYCIN DERIVATIVES.
HN2001000281A (en) NEW IMIDAZOTRIAZINONAS REPLACED
BR0110751A (en) Device
PT1263745E (en) SUBSTITUTED 3-PHENYL-5-ALCOXY-1,3,4-OXADIAZOL-2-OES AND ITS USE FOR THE INHIBITION OF SENSITIVE LIPASE TO HORMONES
ES2184131T3 (en) DERIVATIVES OF BENZAMIDINE AND ITS USE AS MEDICINES WITH ANTAGONIST EFFECT OF LTB4.
BR0314058A (en) Branched Alcohol Personal Care Compositions
BR9809847A (en) Device to lower an anchor to the seabed
ECSP034531A (en) SUBSTITUTED DERIVATIVES OF C-CICLOHEXILMETILAMINA
BR0115065A (en) Formatable radiotelephony device
AR030662A1 (en) BETA-TIO-ALFA-AMINO ACIDS, PROCEDURE FOR MANUFACTURING, MEDICINES CONTAINING THESE COMPOUNDS AND THE USE OF THIOAMINO ACIDS FOR THE PREPARATION OF MEDICINES
AR041113A1 (en) PHARMACEUTICAL COMPOSITION PRESENTING A CONSTANT DRUG RELEASE PROFILE
AR029509A1 (en) A PHARMACEUTICAL COMPOSITION BASED ON A PLATINUM COMPOUND (IV) AND THE USE OF SUCH COMPOUND TO PREPARE ANTITUMURAL MEDICINES
RS50002B (en) Eletriptan hydrobromide monohydrate
BR0100828A (en) Corrosion inhibitors
AR023668A1 (en) NEW BENZOILGUANIDINE DERIVATIVES WITH ADVANTAGE PROPERTIES, PROCEDURE FOR THEIR PREPARATION AND ITS USE IN THE PREPARATION OF MEDICINES
ES1048488Y (en) MECHANICAL DEVICE FOR PROLONGING THE ERECTION OF THE PENIS.
UY26523A1 (en) DERIVATIVES OF AMINOMETIL-FENIL-CICLOHEXANONA, PROCEDURE FOR ITS PREPARATION, THE USE OF THE DERIVATIVES OF AMINOMETIL-FENIL-CICLOHEXANONA FOR THE PREPARATION OF MEDICINES THAT CONTAIN THE DERIVATIVES OF AMINOMETIL-FENIL-CICLOHEXANONA
JPS53148865A (en) Lamp supporting device
ES1049650U (en) Improved device for prolonging the erection in the penis. (Machine-translation by Google Translate, not legally binding)
ES1046218Y (en) DEVICE TO KEEP THE ROOMS OF RESES OPEN.

Legal Events

Date Code Title Description
FC Application refused